Skip to main content
logo
Medifast, Inc. (MED)
NYSE: MED · Real-Time Price · USD
12.15
-0.11 (-0.90%)
At close: Oct 30, 2026, 4:00 PM EDT
12.17
+0.02 (0.16%)
After-hours: Oct 30, 2026, 7:30 PM EDT

Medifast Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Oct '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Market Capitalization
1261191091051101401451441882042334137248069941,1181,2531,1872,0711,9642,424
Market Cap Growth (YoY)
-5.59%-15.16%-25.13%-26.85%-41.52%-31.14%-37.74%-65.22%-74.09%-74.71%-76.52%-63.05%-42.20%-32.09%-52.01%-43.07%-48.30%-47.26%-37.51%-20.92%5.36%
Enterprise Value
-25-23-44-51-51-9-5-33559982855896838941,0561,2111,1821,9801,8872,284
Last Close Price
12.1511.5210.6110.1910.6813.6714.0513.4817.6219.1421.8238.3267.2274.8590.2999.67109.01100.97165.88155.59188.97

Price Ratios

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Oct '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
PE Ratio
------39.94-89.7227.83-6.107.296.727.487.898.737.8613.2011.9214.78
Forward PE
-53.7753.7753.7753.7753.7753.7753.7738.00174.0040.7820.1113.0513.4414.899.769.039.5610.8511.0613.75
PS Ratio
0.420.400.340.300.280.330.300.260.310.300.300.460.680.660.720.730.780.721.251.231.59
PB Ratio
0.700.660.550.530.550.650.670.680.890.981.141.963.604.185.366.548.087.8915.999.0911.97
P/TBV Ratio
0.700.660.550.530.550.650.670.680.890.981.141.963.604.185.366.548.087.8915.999.0911.97
P/FCF Ratio
--30.7827.11--217.30-10.67-6.034.294.885.134.634.985.617.0510.2230.4948.77-
P/OCF Ratio
--4580.8412.3728.28-19.51-6.98-5.103.844.554.914.274.645.206.448.7721.6226.94-
PEG Ratio
-0.550.550.550.550.550.550.550.550.550.550.550.550.550.550.550.550.550.550.550.55

EV Ratios

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Oct '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
EV/Sales Ratio
--------0.060.090.130.320.550.560.650.690.760.721.191.181.50
EV/EBITDA Ratio
--------1.262.51-3.034.223.904.535.115.825.639.188.3210.24
EV/EBIT Ratio
--------2.305.48-3.534.664.204.835.416.155.949.618.6410.56
EV/FCF Ratio
---------1.761.793.374.173.924.485.306.8110.1829.1546.85-

Financial Efficiency

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Oct '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Debt / Equity Ratio
0.120.120.140.080.050.060.060.070.080.090.090.100.110.120.130.140.170.180.440.140.16
Debt / EBITDA Ratio
--16.48--5.370.781.140.230.68-0.410.410.190.140.110.130.130.260.130.16
Debt / FCF Ratio
--5.356.88--18.98-1.09-0.520.350.240.160.130.120.120.150.240.830.77-
Net Debt / Equity Ratio
-0.84-0.84-0.72-0.77-0.79-0.75-0.69-0.71-0.70-0.73-0.70-0.64-0.63-0.70-0.67-0.58-0.40-0.28-0.04-0.42-0.38
Net Debt / EBITDA Ratio
6.896.2718.1338.37-5219.30-7.77-5.60-7.93-5.21-6.42-3.05-1.44-0.92-0.77-0.63-0.48-0.30-0.20-0.02-0.40-0.34
Net Debt / FCF Ratio
39.2539.25-35.44103.91-125.36-249.6161.77-11.14-8.59-4.50-2.65-1.60-0.91-0.78-0.62-0.50-0.35-0.36-0.07-2.26-1.28
Asset Turnover
1.181.181.201.301.451.541.711.872.032.212.522.883.423.774.174.124.474.704.724.294.53
Inventory Turnover
4.154.154.324.674.234.083.333.082.993.464.203.763.523.684.123.802.772.853.042.502.57
Quick Ratio
4.124.124.094.013.893.713.522.722.532.352.172.031.631.431.280.940.620.450.330.670.65
Current Ratio
4.824.824.864.804.694.454.473.523.343.112.982.852.432.041.991.751.581.491.291.791.81
Return on Equity (ROE)
-20.69%-20.69%-12.42%-9.80%-9.13%0.12%1.73%-3.32%1.02%3.66%15.01%35.49%55.77%69.80%84.39%73.27%80.31%87.13%96.80%84.29%91.20%
Return on Assets (ROA)
-8.56%-8.56%-4.60%-4.33%-3.34%1.52%2.88%1.32%3.24%2.22%6.99%16.18%25.24%31.43%35.11%32.88%32.33%35.66%36.55%36.53%40.08%
Return on Invested Capital (ROIC)
-84.22%-90.29%-35.98%-34.56%-20.62%9.50%16.88%5.56%11.11%8.30%41.38%86.24%117.03%155.23%153.42%155.06%140.84%184.30%220.61%131.95%130.79%
Return on Capital Employed (ROCE)
-17.60%-18.70%-9.90%-8.80%-6.90%3.10%5.80%2.80%7.00%5.00%15.70%35.80%58.10%77.40%90.80%102.90%112.40%115.70%135.20%90.90%94.60%

Yields

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Oct '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Earnings Yield
-30.38%-34.30%-23.53%-19.05%-17.01%0.18%2.50%-4.87%1.11%3.59%12.57%16.40%13.72%14.87%13.38%12.68%11.46%12.72%7.58%8.39%6.77%
FCF Yield
-3.06%-3.25%3.69%-1.40%1.14%0.46%-1.67%9.37%9.07%16.59%23.31%20.49%19.49%21.62%20.09%17.81%14.19%9.78%3.28%2.05%2.49%
Dividend Yield
-------------8.81%7.13%6.34%5.66%5.80%3.24%3.46%2.71%
Payout Ratio
------0.04%--0.09%-8.54%297.90%78.00%58.89%47.95%67.58%50.01%48.47%39.87%50.00%
Buyback Yield / Dilution
-0.94%-1.73%-0.68%-0.53%-0.07%-0.18%-1.13%0.09%-0.44%-0.35%-0.18%-0.54%0.53%0.99%4.53%6.35%6.04%6.30%3.57%2.04%1.45%
Total Shareholder Return
-0.94%-1.73%-0.68%-0.53%-0.07%-0.18%-1.13%0.09%-0.44%-0.35%-0.18%-0.54%0.53%9.79%11.66%12.69%11.70%12.11%6.80%5.50%4.16%
SEC Filings: 10-K · 10-Q